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A loxP-ﬂanked sequence encoding poly-lysine (pK—binds heparan sulfate proteoglycans) was engineered
onto the 3′-terminus of pIX, and the resulting fusion protein allowed for routine virus propagation. Growth
of this virus on Cre-expressing cells removed the pK coding sequence, generating virus that could only infect
through alternative ligands, such as a tyrosine kinase receptor A (TrkA)-binding motif engineered into the
capsid ﬁbre protein for enhanced infection of neuronal cells. We used a similar approach to swap the pK
motif on pIX for a sequence encoding a single-domain antibody directed towards CD66c for targeted infection
of cancer cells; Cre-mediated removal of the pK-coding sequence simultaneously placed the single-domain
antibody coding sequence in frame with pIX. Thus, we have developed a simple method to propagate virus
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Adenovirus (Ad) vectors are a popular tool for foreign gene delivery
to mammalian cells, in part due to their ability to infect many different
cell types and tissues (Amalﬁtano and Parks, 2002). There are over 50 dif-
ferent Ad serotypes, divided into 6 subgroups (A–F), which vary in the
cell surface receptor they bind and the cell typewhich they preferentially
infect (Havenga et al., 2002). The best characterized andmost commonly
used Ads are based on serotypes 2 and 5, which are very closely related
genetically and biologically (Berk, 2007). Infection of Ad5 begins by
bindingof the capsidﬁbre protein to theCoxsackie-Adenovirus Receptor
(CAR) on the cell surface (Bergelson et al., 1997; Tomko et al., 1997), and
internalization is triggered by a secondary interaction between penton
protein and αvβ3 and αvβ5 integrins (Wickham et al., 1993). Ablation
of CAR and/or integrin binding can dramatically reduce virus infection
in vitro and alters tissue distribution of the vector in vivo (Einfeld et al.,
2001). However, inmice, Ad5 has a very high efﬁciency of uptake by he-
patocytes in the liver, which occurs through a unique mechanism: the
virus hexon capsid protein binds to blood factor X, which then interactswith heparan sulfate on the surface of hepatocytes (Kalyuzhniy et al.,
2008; Waddington et al., 2008). Importantly, swapping the hypervari-
able regions of the Ad5 hexonwith those of Ad48, which does not inter-
actwith factor X, reduces hepatocyte uptake 600-fold, althoughmuch of
the virus is still trapped extracellularly in the fenestrations in the liver,
and is subsequently degraded (Kalyuzhniy et al., 2008). These studies
suggest that effective detargeting of the vector can be achieved and,
when combinedwithmethods to re-target virus infection to cell-speciﬁc
receptors, should lead to vectors with enhanced therapeutic potential
and safety.
A number of Ad capsid proteins can be genetically modiﬁed to dis-
play novel ligands to allow Ad to bind speciﬁc cell types or improve
transduction of CAR-deﬁcient cells. These proteins include ﬁbre, pen-
ton, hexon, and protein IX (pIX), and modiﬁcation of each has met
with varying success (Glasgow et al., 2006). pIX is a minor component
of the Ad virion that associates with the hexons that make up the
facets of the icosahedron (Boulanger et al., 1979). Although involved
in stabilizing the virion, pIX is not essential for virion formation; how-
ever, capsids that are deﬁcient of pIX are heat labile (Colby and Shenk,
1981). In addition to its role as a structural protein, pIX has been im-
plicated as a transcriptional activator and may be involved in virus in-
duced nuclear reorganization (Lutz et al., 1997; Rosa-Calatrava et al.,
2001, 2003); however, these functions are not essential for virus rep-
lication, since viruses deleted of pIX grow to near wildtype levels
(Sargent et al., 2004).
Fig. 1. The efﬁciency of Cre-mediated excision of a poly-lysine coding sequence from
the 3′-terminus of pIX is dependent on the distance between the loxP sites. Panel A:
AdRP2428 is deleted of early region 1 (E1) and E3 and contains the murine secreted
alkaline phosphatase gene (mSEAP) under regulation by the human ubiquitin C pro-
moter (Ubc) and bovine growth hormone polyadenylation sequence (BpA).
AdRP2428 also encodes a pIX gene containing a C-terminal poly-lysine (pK) coding
sequence ﬂanked by loxP sites. Growth of AdRP2428 on Cre-expressing cells results
in removal of the pK coding sequence. AdRP2515 and AdRP2525 are similar in struc-
ture to AdRP2428, but contain loxP sites separated by 118 and 201 bp, respectively
(note: these distances are reported at the distance from the 5′ terminus of the ﬁrst
loxP site to the 5′ terminus of the second loxP site). The FLAG epitope tag is located
immediately after the native pIX sequence, but before the ﬁrst loxP site. Panel B and
C: 293 or 116 cells were infected at an MOI of 3 with AdRP2428, -2515 or -2525
and, 72 h later, total DNA was isolated, digested with MfeI/NotI, and the resulting
fragments separated by agarose gel electrophoresis. The resolved DNA was visualized
by ethidium bromide staining of the gel (Panel B) or by Southern blot analysis using a
probe speciﬁc for the pIX gene (Panel C).
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the Ad capsid. Auto-ﬂuorescent proteinswere fused to pIX of human, ca-
nine, and bovine viruses, and infection of the resulting virus could be
tracked in vitro and in vivo (Le et al., 2004, 2005; Meulenbroek et al.,
2004; Zakhartchouk et al., 2004). Other additions to pIX have included
luciferase (Matthews et al., 2006), the herpes simplex virus thymidine
kinase (HSV-TK) (Li et al., 2005), or complement-inhibiting polypeptides
(Seregin et al., 2010a, 2010b). pIX has also served as a site for addition of
a biotin acceptor peptide (BAP) formetabolic biotinylation of the Ad cap-
sid, allowing for the subsequent avidin-mediated puriﬁcation of the
virus (Campos et al., 2004), or addition of avidin-linked targeting ligands
(Campos and Barry, 2006). Indeed, several studies showed that pIX can
be used as a cell attachment protein, provided suitable cell binding li-
gands are attached to the protein (Campos and Barry, 2006; de Vrij et
al., 2008; Dmitriev et al., 2002; Poulin et al., 2010; Vellinga et al.,
2004). One curious ﬁnding from these studies was that the nature of
the targeting ligand can have a signiﬁcant inﬂuence on the efﬁciency of
retargeting using pIX. Although using transferrin as a targeting ligand
could effectively enhance virus infection of C2C12 muscle cells, using
an antibody directed towards CD71, the transferrin receptor, did not
(Campos et al., 2004). In contrast, both transferrin and anti-CD71 func-
tioned as efﬁcient targeting ligandswhen conjugated to Ad ﬁbre. Similar
observations were made by Corjon et al. (2008) using a different com-
bined genetic- and chemical-labeling system for pIX. Barry and co-
workers postulated that, unlike Ad ﬁbre, pIX (and its targeting ligand)
may not dissociate from the capsid in the early endosome, resulting in
the Ad particle remaining bound to the receptor in the endosome;
thus, the virus is “trapped” in the endosome which prevents the viral
DNA from reaching the nucleus (Campos et al., 2004). Thus, although
pIX can be used to display targeting ligands on the surface of the
Ad capsid allowing for efﬁcient cell binding, the nature of the ligand
may signiﬁcantly inﬂuence whether it can successfully complete
subsequent steps of infection.
Ad vectors that are detargeted (i.e. containmutationswithin speciﬁc
capsid proteins that prevent the virus from attaching to its normal re-
ceptors), cannot be easily propagated. Detargeting prevents the virus
fromutilizing the normal Ad infection route, and the cell surface epitope
towhich the virusmay be retargeted is not necessarily expressed on the
cells used for virus propagation (e.g. 293 cells; Graham et al., 1977).We
thus investigated whether pIX could be employed as a transient cell at-
tachment protein for propagation of vector with CAR-binding ablated/
retargeted ﬁbre proteins. In this scenario, a common, low-afﬁnity cell
bindingmotif (such as polylysine (pK)which binds heparan sulfate pro-
teoglycans, HSPG) could be transiently displayed on pIX in order to
allow for efﬁcient propagation of vector; however, once pK is removed
from the virus capsid, infection could only proceed from a second,
cell type-speciﬁc targeting ligand present on a different Ad capsid
protein, such as ﬁbre. Development of this system was the goal of
this study.
Results
pIX for transient display of cell attachment peptides
We constructed a virus that contained a ﬂoxed pK motif on the
C-terminus of pIX, and tested its ability to act as a transient cell surface
binding protein. pK bindsHSPG on the surface ofmost cell types, and has
been used successfully to enhance Ad transduction on a variety of cell
types (Bramson et al., 2004; Dmitriev et al., 2002; Wickham et al.,
1996). Several studies have shown that the Cre recombinase can act
upon the viral DNA to excise elements contained between two tandemly
arrayed loxP recognition sites (Anton and Graham, 1995; Parks et al.,
1996). AdRP2428 encodes a pIX gene under endogenous regulation but
containing a ﬂoxed pK-encoding motif on its 3′-terminus, and also en-
codes a murine secreted alkaline phosphatase (mSEAP) reporter gene
expression cassette replacing the early region 1 (E1)-deletion (Figs. 1Aand 2A). We initially examined the efﬁciency of Cre-mediated excision
of the DNA element encoding the pK motif by analyzing DNA from
infected 293 versus Cre-expressing 116 cells. In AdRP2428-infected
293 cells, we observed an MfeI/NotI DNA band of ~250 bp for pIX,
which is as predicted based on the sequence of the virus (Fig. 1B). On
116 cells, Cre-mediated excision of the region encoding the pK
motif from this virus should result in the disappearance of the
250 bp fragment and the formation of a unique 199 bp fragment;
however, this region of the agarose gel was relatively indistinct. To
better visualize the viral DNA bands, we performed Southern blot
hybridization. Infection of 116 cells with AdRP2428 did result in
the formation of the expected 199 bp fragment, but we also observed
a signiﬁcant amount of the unexcised 250 bp band (Fig. 1C). This
data suggests that Cre-mediated excision of the pK motif in
AdRP2428 was incomplete.
Fig. 2. Examination of protein content in infected cells and puriﬁed virions before and
after Cre-mediated excision of the DNA element encoding the polypeptide present on
the C-terminus of pIX. Panel A: Protein sequence of the modiﬁed pIX in the viruses
used in this study. Panel B: 293 or Cre-expressing 116 cells were infected at an MOI
of 3 with AdRP2330, -2428, -2515 or -2525 and, 24 h later, total cellular protein was
isolated, separated by SDS-PAGE, and analyzed by immunoblot for expression of the
FLAG-tagged pIX. Panel C: Proteins from cesium chloride buoyant density gradient pu-
riﬁed virions of AdRP2330, - 2428 and -2525, or the same virus propagated on the Cre-
expressing 116 cells (AdRP2428ex and -2525ex) were separated by SDS-PAGE and an-
alyzed by immunoblot for expression of the FLAG-tagged pIX.
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mediated excision
Cre-mediated excision of virus-encoded elements is generally
very efﬁcient, especially using the 116 cell line which expresses Cre
at very high levels (Palmer and Ng, 2003). AdRP2428 has a minimal
distance between the two loxP sites of 60 bp, as measured from the
5′ terminus of the ﬁrst loxP site to the 5′ terminus of the second
loxP site (Fig. 1A). Previous studies showed that the efﬁciency of
Cre-mediated intermolecular recombination is strongly inﬂuenced
by the distance between the two loxP sites; recombination between
loxP sites less than 116 bp is relatively inefﬁcient, possibly due to
the length of DNA required to efﬁciently loop into a circle to align
the loxP sites (Hoess et al., 1985; Shore et al., 1981). We generated
two additional viruses that contained the same pK motif ﬂanked by
loxP sites separated by 118 or 201 bp, designated AdRP2515 and
AdRP2525, respectively (Fig. 1A). These distances were speciﬁcally
chosen to be almost exact multiples of the helical repeat length
(10.6 bp), since this would allow for better alignment of the loxP sites
upon DNA looping thereby maximizing the efﬁciency of Cre-mediated
excision (Hoess et al., 1985). AdRP2525 also encodes a 30 Å alpha-helical
spacer between pIX and pK, which extends the binding motif from the
virus capsid potentially improving accessibility of the binding ligand to
the cell surface (Vellinga et al., 2004). In 293 cells, AdRP2515 and
AdRP2525 produced MfeI/NotI fragments of expected size (290 and
374 bp, respectively) (Figs. 1B and C). Excision of the ﬂoxed pK region
in 116 cells was very efﬁcient and resulted in formation of a novel
199 bp band, although overexposure of the autoradiograph showed a
minor signal of a size consistentwith parental unexcisedDNA, suggesting
that excision was efﬁcient but not complete (data not shown). It is not
clearwhether this unexcised species is due to replicated DNA that has es-
caped Cre-mediated excision or if it is due to virus from the infecting in-
oculum which has failed to uncoat and is thus protected from Cre.
Nevertheless, these results indicated that Cre can be used to very efﬁ-
ciently excise a ﬂoxed fragment from the terminus of the pIX gene in
the viral genome, provided the loxP sites are separated by aminimal, op-
timal distance.
Analysis of protein expression from viruses containing the ﬂoxed pK mo-
tif on pIX
To examine expression of the modiﬁed pIX protein, we again
infected 293 cells and 116 cells with AdRP2428, -2515 or -2525 and
used immunoblotting to compare protein expression relative to our
control virus, AdRP2330, which contains a C-terminal FLAG epitope
tag on pIX (Meulenbroek et al., 2004; Poulin et al., 2010). For
AdRP2428, infection of 293 cells resulted in the production of a larger
pIX compared to AdRP2330 due to the addition of the 11 amino acids
encoded by the loxP site and short ﬂexible linker sequence located up-
stream of the 6 lysines (18.7 kDa versus 15.4 kDa for AdRP2428 and
AdRP2330, respectively) (Figs. 2A and B). AdRP2428 also produced
low-levels of two additional larger protein species (~23 kDa), but the
nature of these species is unclear. Infection of the Cre-expressing 116
cells with AdRP2330 had no effect on the size of pIX produced from
the virus; in contrast, for AdRP2428-infected cells,we observed a reduc-
tion in the size of the pIX species due to Cre-mediated removal of the pK
coding sequence from the 3′-terminus of pIX gene. However, pK exci-
sion was inefﬁcient, as the majority of the protein within the cell was
the larger pK-containing species. Once again, although we have
shown that ﬂanking the pK sequence on the 3′-terminus of pIX with
lox sites can result in removal of this element from the viral DNA,
which translates into loss of this element from the C-terminus of the
protein, excision is inefﬁcient when the distance between the loxP
sites is too small.
We also analyzed pIX protein expression fromour viruses containing
a greater distance between the loxP sites. Infection of 293 cells withthese viruses resulted in production of modiﬁed pIX of 19.5 and
22.6 kDa for AdRP2515 and AdRP2525, respectively (Fig. 2B). In the
Cre-expressing 116 cells, both of these viruses demonstrated improved
excision of the ﬂoxed element compared to AdRP2428, as evidenced by
the single pIXbandof ~17 kDa. Thus, excision of the pKencoding element
from the DNA translates directly to loss of the pK element frompIX in the
infected cells.
We next examined incorporation of pIX into virions for viruses
grown on 293N3S or Cre-expressing 116 cells. Large scale preparation
and puriﬁcation of AdRP2428 or AdRP2525 from 116 cells should result
in excision of the ﬂoxed pK motif on pIX, and these viruses were desig-
nated AdRP2428ex and AdRP2525ex, respectively. The pIX content of
the cesium chloride buoyant density gradient puriﬁed virionswas exam-
ined by immunoblot. AdRP2428 virions contained the ~18 kDa pIX–pK
fusion protein and the higher mobility species that was also present in
the infected cell lysates (Fig. 2C). Growth of this virus on 116 cells
resulted in virions that contained both the pIX–pK and the pIX lacking
the pK motif, in roughly equal amounts. This latter result was not sur-
prising given the inefﬁcient removal of the pK motif and the relative
level of each protein present in the cell (Figs. 1 and 2B). For AdRP2525ex,
themajority of pIX contained in the virion lacked the pKmotif, although
a small quantity of pIX–pK also appeared to be present. Sincemost if not
all of the pIX protein present in AdRP2525-infected 116 cells lacks the pK
Fig. 3. The presence of a pKmotif on pIX allows for enhanced infection of cells lacking the
coxsackie-adenovirus receptor (CAR). Panel A: A549 (CAR+) or CHO cells (CAR−) were
infected with an MOI of 50 with AdRM48 (native pIX), AdRP2525 or AdRP2525ex and,
24 h later, total cellular proteins were isolated and analyzed for alkaline phosphatase
(AP) activity, reported as relative light units. Data is representative of two independent ex-
periments, and error bars represent the range of values. Panel B: AdRP2525 was pre-
incubated with varying concentrations of heparin for 15 min, and used to infect CHO
cells in duplicate. Twenty-four hours later, crude extracts were prepared from the cells
and analyzed for AP activity. Data is representative of two independent experiments, and
error bars represent the range of values. Panel C: AdMAD26 (CAR-binding ablated, pIX–
pK) or AdAVH6-2F (wildtype for both ﬁbre and pIX) were pre-incubated with heparin
for 15 min, and used to infect A549 cells in duplicate. Twenty-four hours later, the level
of infection was determined by visual inspection using ﬂuorescence microscopy, and the
level of infection for the heparin-treated virus expressed relative to untreated virus.
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from the initial inoculum and have not undergone uncoating and repli-
cation in the 116 cells. Thus, we conclude that the Cre/loxP system can
be used to remove an element on the 3′ terminus of pIX.
Presentation of pK on pIX enhances infection of cells lacking CAR
We next tested whether inclusion of pK on pIX mediates enhanced
infection of cells lacking CAR, and whether this effect is abolished with
the Cre-excised virus. We infected A549 (CAR+) and CHO (CAR−)
cells with control virus AdRM48 (wildtype pIX) or AdRP2525 that had
been propagated on 293 or 116 cells (resulting in removal of pK from
pIX, AdRP2525ex), and monitored the level of infection by reporter
gene assay. Infection of A549 cells with all three of the viruses led to a
similar level of transgene expression, suggesting that infection of this
cell line occurs primarily through CAR-mediated binding and uptake
(Fig. 3A). Infection of CHO cells with AdRM48 led to an almost 100-
fold reduction in reporter gene expression relative to the level observed
on A549 cells, clearly showing that Ad does not infect CAR-negative cells
efﬁciently. In contrast, infection of CHO with AdRP2525 led to a modest
3-fold reduction in reporter gene expression relative to that observed on
A549 cells, suggesting that the pK motif on pIX enhanced infection of
CAR− cells. Infection of CHO cells with AdRP2525ex, which lacks the
pKmotif on pIX, shows a similar ~100-fold reduction in reporter gene ex-
pression, relative to A549 cells, as was observed for the AdRM48 control
virus. Thus, growth of AdRP2525 on 116 cells resulted in removal of the
pK coding sequence from pIX, leading to reduced infection of this virus
on cells lacking the primary Ad receptor.
To verify that AdRP2525 was infecting the CHO cells through inter-
action of the pKmotif located on pIX with HSPG located on the cell sur-
face, we pretreated virus with varying concentrations of heparin, to
block pIX–pK interaction, and examined the level of infection on CHO
cells. Incubation of AdRP2525 with 10 μg/ml heparin led to a ~50% re-
duction in transduction of CHO cells, and infection was further reduced
with higher concentrations of heparin (N95% reduction at 250 μg/ml
heparin) (Fig. 3B). We also examined the effect of heparin on pIX–pK-
mediated infection of A549 cells. AdMAD26 contains speciﬁc mutations
in the ﬁbre knob domain that dramatically reduces the ability of the
virus to bind to cells through CAR (Jakubczak et al., 2001), but contains
an identical pIX–pK as found in AdRP2525. We compared infection of
AdMAD26 with AdAVH6-2pK (wildtype ﬁbre and pIX) in the presence
and absence of heparin. Preincubation of AdAVH6-2F with 10 μg/ml
heparin reduced infection on A549 cells by approximately 20%
(Fig. 3C). In contrast, preincubation of AdMAD26with the same concen-
tration of heparin led to an 80% reduction in infection efﬁciency. Taken
together, these data suggest that presentation of a pKmotif on pIX of Ad
led to enhanced viral infection of cells through binding to HSPG located
on the cell surface, and removal of this element through Cre-mediated
excision effectively abolishes this effect, returning infection to back-
ground levels.
Transient display of pK on pIX can be used to rescue retargeted Ad virus
ablated for CAR binding
We next used the pIX–pK approach to rescue a virus that was ab-
lated for binding to the native Ad receptor but contained within the
HI loop of ﬁbre knob an epitope from neuronal growth factor (NGF)
previously identiﬁed to interact with the tyrosine kinase receptor A
(TrkA) (LeSauteur et al., 1995) (Fig. 4A). This virus, AdRP2866, was
grown on 293 or 116 cells (generating AdRP2866ex in which the pK
coding sequence on pIX was excised), and infection of the resulting
puriﬁed virus was examined on the control A549 cell line or PC12
cells which express the TrkA receptor (Kaplan et al., 1991). Treatment
of A549 (lung cells) or PC12 cells (neuronal cells) with the AdAVH6-
2F control virus resulted in efﬁcient infection of both cell lines, clearly
illustrating the relative lack of speciﬁcity of normal Ad infection(Fig. 4B). For AdRP2866, which is ablated for binding to CAR, we ob-
served an over 100-fold decrease in infection on both cell lines rela-
tive to AdAVH6-2F. For AdRP2866ex, we observed a further 10-fold
decrease in infection of A549 cells relative to AdRP2866, suggesting
that the primary mode of infection for AdRP2866 on A549 cells was
through the pKmotif present on pIX, and removal of this motif abolishes
infection. However, on PC12 cells, infection by AdRP2866ex was 10-fold
higher thanonA549 cells, indicating that this virus had greater speciﬁcity
for infection of cells of neuronal origin expressing theNGF receptor, TrkA.
Fig. 4. Inclusion of an NGF peptide in the HI-loop of ﬁbre enhances infection of neuronal cells expressing TrkA. Panel A: Structure of viruses used to test TrkA targeting. AdAVH6-2F is
primarily derived from Ad5, and contains the native Ad5 pIX but the Ad2 wildtype ﬁbre. AdRP2866 is similar in structure to AdAVH6-2F, but contains the same pIX–loxP–pK–loxP
cassette as AdRP2525, mutations that disrupt CAR binding in the Ad2 ﬁbre (designated K01) and a peptide from NGF in the HI-loop of the Ad2 ﬁbre knob. For AdRP2866, the amino
acid sequence inserted within the HI-loop of ﬁbre is shown (the NGF-derived peptide in larger font), along with the ﬂanking four amino acids of the wildtype ﬁbre sequence.
AdAVH6-2F andAdRP2866 have an identical enhanced green ﬂuorescent protein (eGFP) reporter geneunder regulation by the human cytomegalovirus immediate early enhancer/promoter
(CMV) and BpA. Panel B: A549 or PC12 cells were infected with 108 viral particles of AdAVH6-2F, AdRP2866 or AdRP2866ex and, 24 h later, the level of infection was determined by visual
inspection using ﬂuorescence microscopy, and reported as the percentage of cells in themonolayer expressing eGFP. Data is representative of two independent experiments, and error bars
represent the range of values.
150 K.L. Poulin et al. / Virology 420 (2011) 146–155Taken together, these data show that the Cre/loxP system can be used to
transiently display cell binding motifs in pIX for rescue of CAR-binding
ablated, retargeted Ad.
Use of Cre/loxP recombination to swap the binding motif on pIX
Previously, we showed that large polypeptides can be fused to pIX
and subsequently incorporated into the Ad capsid to either monitor
virus trafﬁcking within the cell in vivo (Meulenbroek et al., 2004), or as
targeting ligands to redirect virus infection (Poulin et al., 2010). In this
latter study, we showed that fusion of a single-domain antibody directed
to CD66c (carcinoembryonic antigen-related cell adhesion molecule
family member 6 [CEACAM6]) redirected virus binding to cancer cells
expressing the appropriate epitope (Poulin et al., 2010). Although addi-
tion of such large retargeting polypeptides can be accommodated on
other capsid proteins, such as a highly modiﬁed ﬁbre protein (Li et al.,
2006), pIX seems to bemore tolerant of the addition of this and a variety
of different proteins (Parks, 2005). We therefore investigated whether
the Cre/loxP system could be used to swap the polypeptide present on
the C-terminus of pIX from a general binding ligand (pK) to a cell-type
speciﬁc targeting ligand (AFAI, a single-domain antibody recognizing
CD66c; Zhang et al., 2004). We designed a virus, AdRP2924, which was
ablated for CAR binding and encoded a pIX with a ﬂoxed pK coding re-
gion at the 3′-terminus (Fig. 5A). In addition, Cre-mediated removal of
the pK coding sequence would result in fusion of the AFAI coding se-
quence in framewith pIX, generating virions containing thepIX–AFAI fu-
sion protein. We examined protein expression from AdRP2924 on 293
and Cre-expressing 116 cells relative to AdGT111 (pIXwith a C-terminal
FLAG tag) and AdRP2823 (pIX–AFAI; Poulin et al., 2010). On 293 cells,AdRP2924 produced a protein of ~23 kDa, consistent with the expected
size of pIX–pK (Fig. 5B). AdRP2823 produced a pIX–AFAI fusion protein
of ~36 kDa. As expected, growth of AdGT111 and AdRP2823 on Cre-
expressing 116 cells did not result in a change in the size of the pIX spe-
cies. In contrast, we observed a change in migration of the pIX species
produced from AdRP2924 from 23 kDa to 30 kDa. Of note, the pIX–
AFAI encoded by AdRP2924ex does not contain the 30 Å alpha-helical
spacer, resulting in a protein of reduced size compared to that encoded
by AdRP2823.We next examined the level of incorporation of themod-
iﬁed pIX into Ad virions. The pIX–AFAI species encoded by AdRP2823
and AdRP2924ex were incorporated into Ad capsids at a similar efﬁ-
ciency, which was lower than the level of incorporation of pIX in
AdRP2330 and AdRP2924 (Fig. 5C). AdRP2924ex virions also appeared
to contain a smaller pIX species which was slightly smaller than the
pIX–pK species contained in parental AdRP2924, but the identity of
this protein is not clear. Taken together, these results demonstrate
that the Cre/loxP system can be used to swap the polypeptide presented
on the C-terminus of pIX.
As a ﬁnal test, we examined the infection efﬁciency of AdRP2924
and AdRP2924ex on A549 cells in the absence or presence of heparin.
Virus was pretreated with 10 μg/ml heparin, to block pIX–pK, and the
infection efﬁciency examined 24 h later through simple visual inspec-
tion of infected monolayers. For AdRP2924, pretreatment of the virus
with heparin resulted in a ~80% reduction in infection efﬁciency due
to blocking of the ability of the virus to infect using the pKmotif present
on pIX (Fig. 5D). In contrast, pretreatment of AdRP2529ex with heparin
had only a minor effect on infection efﬁciency. We showed previously
that infection of A549 cells with virus displaying AFAI on pIX could be
blocked by the addition of soluble AFAI, showing the speciﬁcity of the
Fig. 5. Use of Cre/loxP recombination to swap the binding motif on pIX. Panel A: AdRP2924 contains an eGFP reporter gene and the K01 ﬁbre mutation that ablates binding to CAR.
This virus has the same pIX–loxP–pK–loxP cassette as AdRP2525. Growth of AdRP2924 on Cre-expressing 116 cells results in removal of the pK-coding sequence and placement of
the AFAI coding sequence in frame with pIX. To emphasize the nature of the pIX species produced from AdRP2924 and AdRP2924ex, the stop codon for the fusion proteins is in-
dicated. For both AdRP2924 and AdRP2924ex, the FLAG epitope tag is located immediately after the native pIX sequence, but before the loxP site. Panel B: 293 or Cre-expressing 116
cells were infected with AdGT111 (pIX–FLAG), AdRP2823 (pIX–AFAI) or AdRP2924 at an MOI of 3 and, 24 h later, crude protein extracts were prepared and analyzed by immuno-
blot for expression of pIX (αFLAG) or ﬁbre. Panel C: Proteins from cesium chloride buoyant density gradient puriﬁed virions of AdRP2330,-2823, -2924 or -2924ex were separated
by SDS-PAGE and analyzed by immunoblot for expression of the FLAG-tagged pIX or ﬁbre as a loading control. Panel D: AdRP2924 or AdRP2924ex were pretreated with 10 μg/ml
heparin and used to infect monolayers of A549 cells. Twenty-four hours later, the level of infection was determined by visual inspection, and the level of infection for the heparin-
treated virus expressed relative to untreated virus. Data is representative of three independent experiments, and error bars represent the range of values.
151K.L. Poulin et al. / Virology 420 (2011) 146–155infection for CD66c (Poulin et al., 2010). Thus, the Cre/loxP system can
be used to swap the cell binding ligand present on the C-terminus of
pIX from a general cell binding epitope to a cell-type speciﬁc targeting
ligand, enhancing cell-type speciﬁc infection.
Discussion
Adenovirus-based vectors are a popular tool for foreign gene de-
livery into mammalian cells, in part due to their ability to infect
many different cell types and tissues (Amalﬁtano and Parks, 2002;
Berk, 2007). However, Ad infection promiscuity is a major drawback
for many gene therapy studies where cell-type or tissue-speciﬁc in-
fection is desired. Re-targeting of Ad vectors to alternative cell recep-
tors can be accomplished through the addition of targeting ligands to
any of several capsid proteins, including ﬁbre, penton, hexon, and
protein IX (pIX), and modiﬁcation of each has met with varying suc-
cess (Glasgow et al., 2006). Unfortunately, detargeting the vector
through ablation of ﬁbre binding to CAR, the primary receptor for Ad
serotype 5, creates viruses that are difﬁcult to propagate since they donot readily infect cell lines commonly used for generation of Ad stocks.
There have been a number of systems developed to circumvent the
problem of propagating a de-targeted Ad vector. Perhaps the most di-
rect system is the use of a 293-derived cell line that stably expresses
the wildtype Ad ﬁbre; virions recovered from this cell line contain a
combination of wildtype and modiﬁed ﬁbre, but incorporate exclusively
modiﬁed ﬁbre when subsequently propagated in normal 293 cells (Von
Seggern et al., 1998). Alternatively, 293 cells that express a membrane
bound single-chain antibody to a 6-histidine tag have been used as a
pseudo-receptor for virus containing a his-tag on a viral protein (Douglas
et al., 1999). In this study, we showed that pIX could be used to display a
general cell binding motif that can be used for propagation of an other-
wise detargeted/retargeted vector (Fig. 4). Importantly, the sequence
encoding this element was ﬂanked by loxP sites such that it can be sub-
sequently removed, thus allowing for speciﬁc infection through alterna-
tive binding ligands present elsewhere on the capsid. The efﬁciency of
excision was dependent on the distance between the two loxP sites
(Fig. 1), primarily due to the minimum length required to form a closed
circle of DNA during the Cre-mediated recombination reaction
Table 1
Viruses used in this study.
Virus Transgene type pIX modiﬁcationa Fibre modiﬁcation
AdAVH6-2F eGFP – –
AdGT111 – – –
AdMAD26 eGFP loxP–pK–loxP (201 bp)b K01
AdRM48 mSEAP – –
AdRP2330 – – –
AdRP2428 mSEAP loxP–pK–loxP (60 bp)b –
AdRP2515 mSEAP loxP–pK–loxP (118 bp)b –
AdRP2525 mSEAP loxP–pK–loxP (201 bp)b –
AdRP2823 eGFP AFAI –
AdRP2866 eGFP loxP–pK–loxP (201 bp)b K01/NGF peptide
AdRP2924 RFP loxP–pK–loxP/AFAI K01
AdRP2924ex RFP loxP–AFAI K01
a With the exception of AdAVH6-2F and AdRM48, all viruses contain a FLAG epitope
tag located immediately after the native pIX sequence.
b Distance between the two loxP sites.
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be separated by a minimum distance of ~82 bp, which, when including
the single loxP site, results in an excised circle of 116 bp. This size ap-
proaches the limit for efﬁcient formation of small DNA mini-circles
(Shore et al., 1981). Perhaps the most common use of the Cre/loxP sys-
tem in the context of Ad is for excision of the viral packaging element
to prevent packaging of the helper virus genome during production of
helper-dependent Ad vectors (Palmer and Ng, 2005). Fortunately, the
distance between the loxP sites which ﬂank the Ad packaging element
in the most commonly used helper viruses, AdLC8cluc and AdNG163
(Palmer and Ng, 2003; Parks et al., 1996), are ~230 bp and are thus
well within the range for efﬁcient excision.
Although we have focused this study on using Cre/loxP to tran-
siently display a cell binding epitope on pIX, a similar approach
could be used to transiently display pK, or other cell binding motifs,
on the C-terminus of Ad ﬁbre protein or other capsid proteins. We
also showed that Cre/loxP can also be used to “swap” the identity of
the fusion polypeptide present on pIX (Fig. 5). Once again, a similar
approach could be used to swap polypeptides present in Ad ﬁbre or
other capsid proteins. These types of modiﬁcations can be combined
with other alterations designed to reduce Ad promiscuity such as mu-
tations of the Ad ﬁbre protein to prevent CAR binding (Roelvink et al.,
1999), penton protein to prevent integrin binding (Einfeld et al.,
2001), or hexon protein to prevent liver cell transduction (Kalyuzhniy
et al., 2008; Waddington et al., 2008). For maximum de-targeting,
mutation of all three capsid proteins is likely required. Undoubtedly,
the ability to target Ad to speciﬁc cell types will enhance many re-
search efforts, and provide a technology which will be invaluable to
many researchers investigating the use of Ads for gene delivery in
various preclinical models and, ultimately, clinical trials of genetic
and acquired disease.
Materials and methods
Cell culture
All cell culture media and reagents were obtained from Invitrogen
(Burlington, ON). 293 (Graham et al., 1977), 293N3S [a 293 cell line
adapted for growth in suspension culture (Graham, 1987)] and
A549 cells were grown in a monolayer in minimum essential medium
(MEM) supplemented with 100 U of penicillin per ml, 100 μg of strep-
tomycin per ml, 2.5 μg fungizone per ml, and 10% fetal bovine serum
(FBS). Chinese hamster ovary (CHO) cells were grown in Ham's F10me-
dium, supplementedwith 10% FBS andantibiotics/antimycotic. The PC12
rat pheochromocytoma cell line was maintained in Dulbecco's Modiﬁed
EagleMedium (DMEM) supplementedwith 10% FBS and antibiotic/anti-
mycotic (Greene and Tischler, 1976), and grown on Primaria tissue cul-
ture dishes (Falcon, BD). The 293N3S-derived cell line that stably
expresses the Cre recombinase, 116 cells (Palmer and Ng, 2003), was
propagated in complete MEM supplemented with 0.1 mg/ml G418,
and was kindly provided by Dr. Philip Ng (Baylor College of Medicine,
Houston, TX).
Generation and propagation of viruses
Methods for propagation of Ad vector in 293, 293N3S or 116 cell
suspension have been previously described (Palmer and Ng, 2003;
Ross and Parks, 2009). All viruses used in this study were constructed
using a combination of traditional cloning and RecA+, bacterial-me-
diated recombination (Chartier et al., 1996; Ross and Parks, 2009),
and are described in Table 1. AdRM48 is an early region 1 (E1)/E3 de-
leted Ad vector that contains the murine secreted alkaline phospha-
tase gene (Christou and Parks, 2011; Maelandsmo et al., 2005;
Muruve et al., 2004) under regulation by the human ubiquitin C
(Ubc) promoter and the bovine growth hormone polyadenylation se-
quence (BpA) replacing the E1-deletion. AdRM48 also encodes thenative Ad5 pIX and ﬁbre genes. AdAVH6-2F is an E1/E3-deleted Ad
vector encoding enhanced green ﬂuorescent protein (eGFP) under
regulation by the human cytomegalovirus (CMV) immediate-early pro-
moter/enhancer and BpA. Although primarily based on Ad5, AdAVH6-2F
contains the Ad2 ﬁbre gene, as has been described previously (Bramson
et al., 2004). AdRP2823 is an E1/E3-deleted Ad encoding eGFP under the
regulation of the CMVpromoter/enhancer andBpA replacing the E1-dele-
tion and a pIX–AFAI fusion protein in the native position in the Ad ge-
nome, and has been described previously (Poulin et al., 2010). AFAI is a
single-domain antibody that recognizes CD66c (carcinoembryonic anti-
gen-related cell adhesion molecule family member 6 [CEACAM6])
(Zhang et al., 2004). AdRP2330 and AdGT111 are deleted of E1 and E3,
and contain a FLAG epitope tag on the C-terminus of pIX (Poulin et al.,
2010).
All of the viruses used to test infection of cells mediated by a C-termi-
nal polylysine (pK)motif present on pIX have the same general structure
shown in Fig. 1A. Within these constructs, the pK coding sequence is
ﬂanked by loxP sites such that, upon infection of a cell line which ex-
presses the bacteriophage P1 Cre recombinase, the pK coding sequence
is removed. Cloning of these viruses was as follows. A 1.0 kb XmaI frag-
ment from pRL20 (Poulin et al., 2010) was used to replace a 180 bp
XmaI fragment in pΔE1Sp1A (Bett et al., 1994), which adds a FLAG epi-
tope tag immediately following the native pIX sequence, followed by
NheI and NotI restriction sites to the C-terminus of pIX, and designated
pRP2412. A synthetic oligonucleotide 5′-CT AGC ATA ACT TCG TAT AGC
ATA CAT TAT ACG AAG TTA TCG AAA AAG AAG AAA AAG AAA AAG
TAA ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA TAA GC and its
complement, containing a loxP–polylysine–loxP module, were cloned
into NheI/NotI digested pRP2412, generating pRP2414. The multiple
cloning site of pRP2412was removed from theplasmid throughdigestion
with BamHI and BglII, followed by recircularization, generating pRP2496.
A synthetic oligonucleotide 5′-CT AGC AAA AAG AAG AAA AAG AAA AAG
TAA ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA TGC and its com-
plement, containing the seven lysine binding motif and a loxP site were
cloned intoNheI/NotI digested pRP2496, generating pRP2497. A synthetic
oligonucleotide 5′-AG CTT TCT AGA ATA ACT TCG TAT AGC ATA CAT TAT
ACGAAGTTA TCCCCTAGGGGAGGTGGTGGAGGGGGTGGAGCAG and
its complement, containing a loxP site and a six-residue glycine ﬂexible
linker to further extend the distance between the loxP sites, were cloned
into HindIII/EcoRI digested pRP2497, generating pRP2498. A synthetic ol-
igonucleotide 5′-CT AGT ATC CCA ACC TAT CTG AGC GAA GAT GAA CTG
AAA GCC GCC GAA GCC GCC TTC AAA CGC CAC AAC CCA ACC GCG CCT
AGG A and its complement, corresponding to a 30 Å linker (Vellinga et
al., 2004), were cloned into the AvrII site of pRP2498, generating
pRP2499. A ClaI/MfeI fragment from pShuttle-Ubc-mSEAP, containing
the mSEAP gene (Christou and Parks, 2011; Maelandsmo et al., 2005)
under regulation by the Ubc promoter and BpA sequence, along with
part of the native pIX gene, was cloned into ClaI/MfeI digested pRP2414,
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spectively. These three plasmidswere recombinedwith an Ad5 infectious
backbone plasmid (pRP2014), generating pRP2428, pRP2515, and
pRP2525. These plasmids were rescued into viruses, AdRP2428,
AdRP2515, and AdRP2525 that contain a ﬂoxed pK coding sequence on
the 3′-terminus of pIX in which the loxP sites are separated by 60, 118,
and 201 bp, respectively. The FLAG epitope tag is located immediately
after the native pIX sequence, but before the ﬁrst loxP site. Propagation
of these viruses on Cre-expressing 116 cells results in removal of the se-
quence encoding the pK binding motif on pIX, generating AdRP2428ex,
AdRP2515ex, and AdRP2525ex, respectively.
The virus containing the TrkA binding motif was constructed as
follows. The Ubc-mSEAP expression cassette in pRP2522 was
replaced with an identical eGFP expression cassette as described for
AdAVH6-2F, generating pRP2578. The Ad2 ﬁbre coding sequence in
pRP2075 (Bramson et al., 2004) was modiﬁed to ablate binding to
CAR through introduction of twomutations, S408E and P409A (referred
to herein as K01 mutations), which reduce CAR-dependent infection to
about 1% of wildtype levels (Jakubczak et al., 2001), generating pMAD8.
pRP2578 was recombined with pMAD8, generating pMAD26, which
thus contains the eGFP reporter gene expression cassette replacing the
E1 deletion, a pIX gene containing the pK binding motif ﬂanked by loxP
sites separated by 201 bp, and an Ad2 ﬁbre gene ablated for CAR binding.
Synthetic oligonucleotide 5′-CGGATAC TGCACAGACGAAAAACAATGC
TACGGA TCCGG and its complement, were generatedwhich contain the
epitope region of nerve growth factor (NGF) responsible for binding to
the TrkA receptor (LeSauteur et al., 1995). These oligonucleotides were
cloned into BstBI digested pMAD8, placing the TrkA bindingmotif within
the HI-loop of the Ad2 ﬁbre knob domain, generating pRP2854. pRP2578
was recombinedwith pRP2854 to generate pRP2866. The resulting virus,
AdRP2866, is shown schematically in Fig. 4A, and contains the eGFP re-
porter gene expression cassette replacing the E1deletion, a pIX gene con-
taining the pK binding motif ﬂanked by loxP sites separated by 201 bp,
and an Ad2 ﬁbre gene ablated for CAR binding, but containing a NGF-
derived TrkA binding peptide in the HI loop of the knob domain. Growth
of this virus on Cre-expressing 116 cells results in removal of the se-
quence encoding the pK binding motif on pIX, generating AdRP2866ex.
AdRP2924 was generated as follows. pRP2499 was digested with
NotI (ﬁlled in with Klenow polymerase) and AatII, and ligated to a
6 kb NheI (ﬁlled in)/AatII fragment from pRP2587 (Poulin et al.,
2010), generating pRP2915. Thus, pRP2915 is a pΔE1sp1A-derivedplas-
mid containing a ﬂoxed polylysine-encoding sequence fused to the 3′
end of pIX, with the sequence for the AFAI single-domain antibody
downstream of the 3′ loxP site. Cre-mediated excision of the pK coding
sequence results in fusion of the AFAI coding sequence in-frame with
pIX. A monomeric red ﬂuorescent protein (mRFP, kindly provided by
Roger Tsien, University of California at San Diego; Campbell et al., 2002)
reporter gene under the regulation by the CMV promoter/enhancer and
BpA were cloned in place of the E1 region of pRP2915, generating
pRP2916. Finally, pRP2916 was recombined into pMAD8, generating
pRP2924 which was subsequently rescued and propagated on 293
cells as AdRP2924. Growth of this virus on Cre-expressing 116 cells re-
sults in removal of the sequence encoding the pK binding motif on pIX,
generating AdRP2924ex.
Southern blot analysis
To examine the efﬁciency of Cre-mediated excision of the pK coding
sequence from our various viruses, 35 mm dishes of 293 or 116 cells
were infected with a multiplicity of infection (MOI) of 3 plaque forming
units (pfu) per cell and, 72 h later, the infected cells were lysed in
300 μl SDS-proteinase K buffer (10 mM Tris–HCl (pH 7.4), 10 mM
EDTA, 1% SDS (w/v), 1 mg/ml proteinase K). After an overnight incuba-
tion at 37 °C, the DNA was phenol/chloroform extracted, ethanol pre-
cipitated, and resuspended in 50 μl TE (10 mM Tris–HCl (pH 7.4),
1 mM EDTA). Ten microliters of the resulting DNA was digestedovernight with MfeI/NotI, treated with ribonuclease A, and separated
on a 1.5% agarose gel. DNA was initially visualized with ethidium bro-
mide, then transferred to Hybond-N+ (Amersham-Pharmacia) nylon
membrane using standard techniques (Southern, 1975), probed with
digoxigenin-labeled pRP2522 (described above), and visualized as de-
scribed by the manufacturer (DIG High Prime DNA labeling and Detec-
tion Starter Kit II, Roche).Immunoblot analysis
To examine the efﬁciency of Cre-mediated excision of the pK motif
from our various Ad constructs at the protein level, 293 or 116 cells
were infected with an MOI of 3 of virus and, 24 h later, the medium
was removed and the infected cells were lysed in SDS-PAGE protein
loading buffer (62.5 mM Tris pH 6.8, 25% glycerol, 2% SDS, 0.1% bromo-
phenol blue, 5% 2-mercaptoethanol). The resulting sampleswere boiled
and separated by electrophoresis on a 15% SDS-polyacrylamide gel. The
separated proteins were transferred to a polyvinylidene diﬂuoride
membrane (Immobilon-PSQ,Millipore) and themembranewas probed
with anti-FLAG M2 antibody (Sigma). Binding of the primary antibody
was detected using a goat anti-mouse secondary antibody conjugated
to horseradish peroxidase (Bio-Rad, Hercules, CA, USA) and visualized
by chemiluminescence reaction (Amersham ECL Plus) and autoradiog-
raphy. Analysis of the pIX content of virions was done in a similar man-
ner, although samples were prepared by mixing 3.3×106 pfu in 10 μl
PBS with an equal volume of SDS-PAGE protein loading buffer, as we
have described previously (Smith et al., 2009).Infection assays
To determine whether addition of a pK motif on pIX can mediate
attachment and infection of cells, we analyzed infection of our viruses
on A549 (CAR+) and CHO cells (CAR−) (Soudais et al., 2000). Dupli-
cate 35 mm dishes of CHO cells were infected at an MOI of 50 with
AdRM48, AdRP2525 or AdRP2525ex and, 24 h later, the medium
was removed and the cells lysed in Reporter Lysis Buffer (Promega).
After a single cycle of freeze/thaw, the quantity of mSEAP activity in
the cells was determined using a commercially available chemilumi-
nescence-based kit (Roche). To determine if infection by AdRP2525
was dependent on heparan sulfate proteoglycans (HSPG), virus was
pre-incubated with varying concentrations of heparin for 15 min,
and used to infect CHO cells in duplicate. Twenty-four hours later,
crude extracts were prepared from the cells and analyzed for
mSEAP activity as described above. A similar assay was used to
block AdMAD26 and AdRP2924 infection of A549 cells.
To examine whether inclusion of an NGF motif in the HI loop of
ﬁbre could mediate infection of TrkA-expressing cells, 35 mm dishes
of A549 (TrkA−) or PC12 (TrkA+) cells were infected with 108 or
107 virus particles of AdAVH6-2F, AdRP2866 or Ad2866ex and, 24 h
later, the level of infection was determined by visual inspection
using ﬂuorescence microscopy, and reported as the percentage of
cells in the monolayer expressing eGFP.Acknowledgments
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